Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The radioisotope contributes significantly to the activity of radioimmunotherapy.
Davis TA, Kaminski MS, Leonard JP, Hsu FJ, Wilkinson M, Zelenetz A, Wahl RL, Kroll S, Coleman M, Goris M, Levy R, Knox SJ. Davis TA, et al. Among authors: wilkinson m. Clin Cancer Res. 2004 Dec 1;10(23):7792-8. doi: 10.1158/1078-0432.CCR-04-0756. Clin Cancer Res. 2004. PMID: 15585610 Clinical Trial.
Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial.
Barcenas CH, Hurvitz SA, Di Palma JA, Bose R, Chien AJ, Iannotti N, Marx G, Brufsky A, Litvak A, Ibrahim E, Alvarez RH, Ruiz-Borrego M, Chan N, Manalo Y, Kellum A, Trudeau M, Thirlwell M, Garcia Saenz J, Hunt D, Bryce R, McCulloch L, Rugo HS, Tripathy D, Chan A; CONTROL Study Investigators. Barcenas CH, et al. Ann Oncol. 2020 Sep;31(9):1223-1230. doi: 10.1016/j.annonc.2020.05.012. Epub 2020 May 25. Ann Oncol. 2020. PMID: 32464281 Free article. Clinical Trial.
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer.
Isaacs C, Herbolsheimer P, Liu MC, Wilkinson M, Ottaviano Y, Chung GG, Warren R, Eng-Wong J, Cohen P, Smith KL, Creswell K, Novielli A, Slack R. Isaacs C, et al. Among authors: wilkinson m. Breast Cancer Res Treat. 2011 Jan;125(1):137-43. doi: 10.1007/s10549-010-1226-z. Epub 2010 Oct 26. Breast Cancer Res Treat. 2011. PMID: 20976541 Free PMC article. Clinical Trial.
Measurement of CP Violation Observables in D^{+}→K^{-}K^{+}π^{+} Decays.
Aaij R, Abdelmotteleb ASW, Abellan Beteta C, Abudinén F, Ackernley T, Adefisoye AA, Adeva B, Adinolfi M, Adlarson P, Agapopoulou C, Aidala CA, Ajaltouni Z, Akar S, Akiba K, Albicocco P, Albrecht J, Alessio F, Alexander M, Aliouche Z, Alvarez Cartelle P, Amalric R, Amato S, Amey JL, Amhis Y, An L, Anderlini L, Andersson M, Andreianov A, Andreola P, Andreotti M, Andreou D, Anelli A, Ao D, Archilli F, Argenton M, Arguedas Cuendis S, Artamonov A, Artuso M, Aslanides E, Ataíde Da Silva R, Atzeni M, Audurier B, Bacher D, Bachiller Perea I, Bachmann S, Bachmayer M, Back JJ, Baladron Rodriguez P, Balagura V, Baldini W, Balzani L, Bao H, Baptista de Souza Leite J, Barbero Pretel C, Barbetti M, Barbosa IR, Barlow RJ, Barnyakov M, Barsuk S, Barter W, Bartolini M, Bartz J, Basels JM, Bashir S, Bassi G, Batsukh B, Battista PB, Bay A, Beck A, Becker M, Bedeschi F, Bediaga IB, Behling NB, Belin S, Bellee V, Belous K, Belov I, Belyaev I, Benane G, Bencivenni G, Ben-Haim E, Berezhnoy A, Bernet R, Bernet Andres S, Bertolin A, Betancourt C, Betti F, Bex J, Bezshyiko I, Bhom J, Bieker MS, Biesuz NV, Billoir P, Biolchini A, Birch M, Bishop FCR, Bitadze A, Bizzeti A, Blake T, Blanc F, Blank JE, Blusk S… See abstract for full author list ➔ Aaij R, et al. Among authors: wilkinson mk. Phys Rev Lett. 2024 Dec 20;133(25):251801. doi: 10.1103/PhysRevLett.133.251801. Phys Rev Lett. 2024. PMID: 39752695
The plausibility of claimed induced seismicity.
Wilkinson M, Mhana N, Wilson MP, Foulger GR, Tezel T, Gluyas JG. Wilkinson M, et al. Sci Rep. 2024 Dec 28;14(1):30846. doi: 10.1038/s41598-024-81632-3. Sci Rep. 2024. PMID: 39730566 Free PMC article.
Type I interferon and mitochondrial dysfunction are associated with dysregulated cytotoxic CD8+ T cell responses in juvenile systemic lupus erythematosus.
Radziszewska A, Peckham H, Restuadi R, Kartawinata M, Moulding D, de Gruijter NM, Robinson GA, Butt M, Deakin CT, Wilkinson MGL, Wedderburn LR, Jury EC, Rosser EC, Ciurtin C. Radziszewska A, et al. Among authors: wilkinson mgl. Clin Exp Immunol. 2024 Dec 25:uxae127. doi: 10.1093/cei/uxae127. Online ahead of print. Clin Exp Immunol. 2024. PMID: 39719886
2,355 results